This inventor holds 2 USPTO granted patents. Top assignee: Fujian Medical University. Active years: 2015-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Fuzhou, CN (2015)
- Fujian Province, CN (2024)
Company Filing History:
Years Active: 2015-2024
Title: Changxi Yu: Innovator in Medicinal Chemistry
Introduction
Changxi Yu is a prominent inventor based in Fuzhou, China. He has made significant contributions to the field of medicinal chemistry, particularly through his research on koumine, an alkaloid with promising therapeutic applications.
Latest Patents
Changxi Yu holds 2 patents that focus on the use of koumine in the treatment of various medical conditions. His first patent details the use of koumine in the preparation of a medicament for the treatment of inflammatory bowel disease. This invention highlights the novel application of koumine, or its pharmaceutically acceptable salts, in addressing this challenging condition. The second patent discusses the use of koumine and its homologues in preparing medications for autoimmune diseases affecting bones and joints, such as rheumatoid arthritis and ankylosing spondylitis. The pharmacological experiments associated with this invention demonstrate that koumine can effectively reduce the generation of antibodies against these autoimmune diseases, improve symptoms, and has a favorable safety profile compared to commonly used clinical drugs.
Career Highlights
Changxi Yu is affiliated with Fujian Medical University, where he continues to advance his research in medicinal chemistry. His work has the potential to lead to the development of new drugs that can significantly improve the treatment of autoimmune diseases.
Collaborations
Changxi Yu collaborates with notable colleagues, including Jian Yang and Ying Xu, who contribute to his research endeavors.
Conclusion
Changxi Yu's innovative work in the field of medicinal chemistry, particularly regarding koumine, showcases his commitment to developing effective treatments for serious medical conditions. His contributions are paving the way for future advancements in drug development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile